NCT05253846View on ClinicalTrials.gov

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

January 5, 2025

Study Completion Date

October 30, 2028

Conditions
Locally Advanced Rectal Cancer
Interventions
DRUG

Irinotecan

chemotherapy treatment

DRUG

Oxaliplatin

chemotherapy treatment

DRUG

Lederfolin

treatment

DRUG

5-Fluorouracil

chemotherapy treatment

RADIATION

Short-course radiotherapy

RT

PROCEDURE

TME

surgery

Trial Locations (1)

56126

U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Universitaria Pisana Dipartimento di Ricerca Traslazionale e Nuove Tecnologie - University of Pisa, Pisa

All Listed Sponsors
lead

Gruppo Oncologico del Nord-Ovest

OTHER